(LRCX) Lam Research - Overview
Sector: TechnologyIndustry: Semiconductor Equipment & Materials | Exchange NASDAQ (USA) | Currency USD | Market Cap: 265.801m | Total Return 192.9% in 12m
Stock
Deposition, Etch, Cleaning, Refurbishment
Total Rating 89
Risk 89
Buy Signal -0.16
Market Cap:
265,801m
Avg Trading Vol: 2.25B USD
Avg Trading Vol: 2.25B USD
ATR:
5.93%
Peers RS (IBD): 73.6
Peers RS (IBD): 73.6
Risk 5d forecast
Volatility65.0%
Rel. Tail Risk-4.09%
Reward TTM
Sharpe Ratio2.16
Alpha155.15
Character TTM
Beta2.374
Beta Downside1.831
Drawdowns 3y
Max DD47.10%
CAGR/Max DD1.29
EPS (Earnings per Share)
EPS CAGR: 15.49%
EPS Trend: 56.3%
EPS Trend: 56.3%
Last SUE: 3.55
Qual. Beats: 8
Qual. Beats: 8
Revenue
Rev. CAGR: 7.60%
Rev. Trend: 32.5%
Rev. Trend: 32.5%
Last SUE: 2.67
Qual. Beats: 6
Qual. Beats: 6
Risks
Technicals:
choppy
Description: LRCX Lam Research
March 05, 2026
Lam Research Corporation (LRCX) manufactures and services semiconductor processing equipment globally. The companys product portfolio includes systems for deposition, etch, and cleaning processes critical in integrated circuit fabrication. This business model relies on continuous innovation to support advancements in semiconductor technology.
LRCX offers specialized equipment such as ALTUS for metallization, SABRE for copper interconnect, and various systems for dielectric and conductor etch applications. The company also provides wafer cleaning solutions and customer support services. The semiconductor equipment sector is highly cyclical, tied to capital expenditure trends in chip manufacturing.
To gain a deeper understanding of LRCXs market positioning and financial health, further research on ValueRay is recommended.
- Semiconductor capital expenditure directly impacts equipment demand
- Geopolitical tensions in Asia disrupt supply chains and sales
- Memory and foundry spending cycles dictate equipment orders
- Research and development investment drives new product adoption
Piotroski VR‑10 (Strict, 0-10)
9.5
| Net Income: 6.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.31 > 0.02 and ΔFCF/TA 9.20 > 1.0 |
| NWC/Revenue: 37.96% < 20% (prev 50.97%; Δ -13.01% < -1%) |
| CFO/TA 0.33 > 3% & CFO 7.12b > Net Income 6.21b |
| Net Debt (-1.70b) to EBITDA (7.50b): -0.23 < 3 |
| Current Ratio: 2.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.27b) vs 12m ago -2.01% < -2% |
| Gross Margin: 49.80% > 18% (prev 0.48%; Δ 4.93k% > 0.5%) |
| Asset Turnover: 99.73% > 50% (prev 81.70%; Δ 18.03% > 0%) |
| Interest Coverage Ratio: 41.06 > 6 (EBITDA TTM 7.50b / Interest Expense TTM 172.9m) |
Altman Z''
10.00
| A: 0.36 (Total Current Assets 14.02b - Total Current Liabilities 6.21b) / Total Assets 21.39b |
| B: 1.47 (Retained Earnings 31.50b / Total Assets 21.39b) |
| C: 0.34 (EBIT TTM 7.10b / Avg Total Assets 20.62b) |
| D: 2.79 (Book Value of Equity 31.40b / Total Liabilities 11.25b) |
| Altman-Z'' Score: 12.44 = AAA |
Beneish M
-2.99
| DSRI: 0.83 (Receivables 3.49b/3.30b, Revenue 20.56b/16.21b) |
| GMI: 0.96 (GM 49.80% / 47.60%) |
| AQI: 1.10 (AQ_t 0.22 / AQ_t-1 0.20) |
| SGI: 1.27 (Revenue 20.56b / 16.21b) |
| TATA: -0.04 (NI 6.21b - CFO 7.12b) / TA 21.39b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of LRCX shares?
As of March 30, 2026, the stock is trading at USD 211.41 with a total of 8,479,372 shares traded.
Over the past week, the price has changed by -9.39%, over one month by -9.50%, over three months by +20.35% and over the past year by +192.93%.
Over the past week, the price has changed by -9.39%, over one month by -9.50%, over three months by +20.35% and over the past year by +192.93%.
Is LRCX a buy, sell or hold?
Lam Research has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy LRCX.
- StrongBuy: 20
- Buy: 4
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LRCX price?
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 274.9 | 30% |
| Analysts Target Price | 274.9 | 30% |
LRCX Fundamental Data Overview
March 28, 2026
P/E Trailing = 43.4538 P/E Forward = 33.557
P/S = 12.9277
P/B = 28.1082
P/EG = 1.6422
Revenue TTM = 20.56b USD
EBIT TTM = 7.10b USD
EBITDA TTM = 7.50b USD
Long Term Debt = 3.73b USD (from longTermDebt, last quarter)
Short Term Debt = 754.0m USD (from shortTermDebt, last quarter)
Debt = 4.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.70b USD (from netDebt column, last quarter)
Enterprise Value = 264.10b USD (265.80b + Debt 4.48b - CCE 6.18b)
Interest Coverage Ratio = 41.06 (Ebit TTM 7.10b / Interest Expense TTM 172.9m)
EV/FCF = 39.65x (Enterprise Value 264.10b / FCF TTM 6.66b)
FCF Yield = 2.52% (FCF TTM 6.66b / Enterprise Value 264.10b)
FCF Margin = 32.40% (FCF TTM 6.66b / Revenue TTM 20.56b)
Net Margin = 30.22% (Net Income TTM 6.21b / Revenue TTM 20.56b)
Gross Margin = 49.80% ((Revenue TTM 20.56b - Cost of Revenue TTM 10.32b) / Revenue TTM)
Gross Margin QoQ = 49.60% (prev 50.43%)
Tobins Q-Ratio = 12.35 (Enterprise Value 264.10b / Total Assets 21.39b)
Interest Expense / Debt = 0.95% (Interest Expense 42.5m / Debt 4.48b)
Taxrate = 13.21% (242.6m / 1.84b)
NOPAT = 6.16b (EBIT 7.10b * (1 - 13.21%))
Current Ratio = 2.26 (Total Current Assets 14.02b / Total Current Liabilities 6.21b)
Debt / Equity = 0.44 (Debt 4.48b / totalStockholderEquity, last quarter 10.15b)
Debt / EBITDA = -0.23 (Net Debt -1.70b / EBITDA 7.50b)
Debt / FCF = -0.25 (Net Debt -1.70b / FCF TTM 6.66b)
Total Stockholder Equity = 9.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 30.14% (Net Income 6.21b / Total Assets 21.39b)
RoE = 62.59% (Net Income TTM 6.21b / Total Stockholder Equity 9.93b)
RoCE = 51.98% (EBIT 7.10b / Capital Employed (Equity 9.93b + L.T.Debt 3.73b))
RoIC = 42.77% (NOPAT 6.16b / Invested Capital 14.41b)
WACC = 14.11% (E(265.80b)/V(270.28b) * Re(14.33%) + D(4.48b)/V(270.28b) * Rd(0.95%) * (1-Tc(0.13)))
Discount Rate = 14.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.17%
[DCF] Terminal Value 62.26% ; FCFF base≈5.74b ; Y1≈6.61b ; Y5≈9.32b
[DCF] Fair Price = 58.81 (EV 71.74b - Net Debt -1.70b = Equity 73.44b / Shares 1.25b; r=14.11% [WACC]; 5y FCF grow 17.85% → 3.0% )
EPS Correlation: 56.30 | EPS CAGR: 15.49% | SUE: 3.55 | # QB: 8
Revenue Correlation: 32.55 | Revenue CAGR: 7.60% | SUE: 2.67 | # QB: 6
EPS current Year (2026-06-30): EPS=5.31 | Chg7d=+0.000 | Chg30d=+0.001 | Revisions Net=+1 | Growth EPS=+28.2% | Growth Revenue=+21.3%
EPS next Year (2027-06-30): EPS=6.90 | Chg7d=+0.000 | Chg30d=+0.021 | Revisions Net=+4 | Growth EPS=+30.0% | Growth Revenue=+23.1%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 12.0% (Discount Rate 14.3% - Earnings Yield 2.3%)
[Growth] Growth Spread = +11.0% (Analyst 23.1% - Implied 12.0%)